Cite
Kinase Inhibitor Screening Displayed ALK as a Possible Therapeutic Biomarker for Gastric Cancer
MLA
Felipe Pantoja Mesquita, et al. “Kinase Inhibitor Screening Displayed ALK as a Possible Therapeutic Biomarker for Gastric Cancer.” Pharmaceutics, vol. 14, no. 9, Sept. 2022, p. 1841. EBSCOhost, https://doi.org/10.3390/pharmaceutics14091841.
APA
Felipe Pantoja Mesquita, Pedro Filho Noronha Souza, Emerson Lucena da Silva, Luina Benevides Lima, Lais Lacerda Brasil de Oliveira, Caroline Aquino Moreira-Nunes, William J. Zuercher, Rommel Mario Rodríguez Burbano, Maria Elisabete Amaral de Moraes, & Raquel Carvalho Montenegro. (2022). Kinase Inhibitor Screening Displayed ALK as a Possible Therapeutic Biomarker for Gastric Cancer. Pharmaceutics, 14(9), 1841. https://doi.org/10.3390/pharmaceutics14091841
Chicago
Felipe Pantoja Mesquita, Pedro Filho Noronha Souza, Emerson Lucena da Silva, Luina Benevides Lima, Lais Lacerda Brasil de Oliveira, Caroline Aquino Moreira-Nunes, William J. Zuercher, Rommel Mario Rodríguez Burbano, Maria Elisabete Amaral de Moraes, and Raquel Carvalho Montenegro. 2022. “Kinase Inhibitor Screening Displayed ALK as a Possible Therapeutic Biomarker for Gastric Cancer.” Pharmaceutics 14 (9): 1841. doi:10.3390/pharmaceutics14091841.